Decline in the AIDS and death rates in the EuroSIDA study: an observational study
A Mocroft, B Ledergerber, C Katlama, O Kirk, P Reiss… - The Lancet, 2003 - thelancet.com
Background Since the introduction of highly active antiretroviral therapy (HAART), little is
known about whether changes in HIV-1 mortality and morbidity rates have been sustained. We …
known about whether changes in HIV-1 mortality and morbidity rates have been sustained. We …
Changing patterns of mortality across Europe in patients infected with HIV-1
Background The introduction of combination antiretroviral therapy and protease inhibitors has
led to reports of falling mortality rates among people infected with HIV-1. We examined the …
led to reports of falling mortality rates among people infected with HIV-1. We examined the …
Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort
D Konopnicki, A Mocroft, S De Wit, F Antunes… - Aids, 2005 - journals.lww.com
Background: Whether hepatitis B (HBV) coinfection affects outcome in HIV-1-infected
patients remains unclear. Objective: To assess the prevalence of HBV (assessed as HBsAg) …
patients remains unclear. Objective: To assess the prevalence of HBV (assessed as HBsAg) …
AIDS across Europe, 1994–98: the EuroSIDA study
A Mocroft, C Katlama, AM Johnson, C Pradier… - The Lancet, 2000 - thelancet.com
Background The clinical presentation of HIV-1 related diseases could have changed after the
introduction of highly active antiretroviral treatment (HAART). We aimed to assess changes …
introduction of highly active antiretroviral treatment (HAART). We aimed to assess changes …
Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe
A Mocroft, O Kirk, SE Barton, M Dietrich, R Proenca… - Aids, 1999 - journals.lww.com
Objectives: To describe changes in haemoglobin over time and to determine the joint prognostic
value of the current haemoglobin, CD4 lymphocyte count and viral load among patients …
value of the current haemoglobin, CD4 lymphocyte count and viral load among patients …
Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy
JK Rockstroh, A Mocroft, V Soriano… - The Journal of …, 2005 - academic.oup.com
ObjectiveTo assess hepatitis C virus (HCV) antibody prevalence in the EuroSIDA cohort,
along with survival, human immunodeficiency virus (HIV)–1 disease progression, virologic …
along with survival, human immunodeficiency virus (HIV)–1 disease progression, virologic …
Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients
A Mocroft, O Kirk, P Reiss, S De Wit, D Sedlacek… - Aids, 2010 - journals.lww.com
Objectives: Chronic kidney disease (CKD) in HIV-positive persons might be caused by both
HIV and traditional or non-HIV-related factors. Our objective was to investigate long-term …
HIV and traditional or non-HIV-related factors. Our objective was to investigate long-term …
Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study
E Martinez, A Mocroft, MA García-Viejo… - The Lancet, 2001 - thelancet.com
Background Risk factors for lipodystrophy in patients infected with HIV-1 treated with highly
active antiretroviral therapy (HAART) containing HIV-1 protease inhibitors are poorly …
active antiretroviral therapy (HAART) containing HIV-1 protease inhibitors are poorly …
[HTML][HTML] Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological …
A Mocroft, JD Lundgren, ML Sabin, AA Monforte… - PLoS …, 2013 - journals.plos.org
Background Few studies have monitored late presentation (LP) of HIV infection over the
European continent, including Eastern Europe. Study objectives were to explore the impact of …
European continent, including Eastern Europe. Study objectives were to explore the impact of …
Association Between Antiretroviral Exposure and Renal Impairment Among HIV-Positive Persons With Normal Baseline Renal Function: the D:A:D Studya
Background. Several antiretroviral agents (ARVs) are associated with chronic renal
impairment, but the extent of such adverse events among human immunodeficiency virus (HIV)–…
impairment, but the extent of such adverse events among human immunodeficiency virus (HIV)–…